AVERE THERAPEUTICS ANNOUNCES $500 MILLION PRIVATE PLACEMENT TO SUPPORT DEVELOPMENT OF ONCE-WEEKLY ORAL IL-23 THERAPY AVR-001

Reuters · 1d ago

Please log in to view news